Summit Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.2M | 54k | 21.90 |
| 2024-06-30 | $266k | 34k | 7.80 |
| 2024-03-31 | $165k | 40k | 4.14 |
| 2023-12-31 | $92k | 35k | 2.61 |
| 2023-09-30 | $53k | 28k | 1.87 |
| 2023-06-30 | $134k | 53k | 2.51 |
| 2022-12-31 | $24k | 5.7k | 4.25 |
| 2022-09-30 | $0 | 21k | 0.00 |
| 2022-06-30 | $21k | 21k | 1.00 |
| 2022-03-31 | $108k | 44k | 2.47 |
| 2021-12-31 | $229k | 85k | 2.71 |
| 2021-09-30 | $886k | 177k | 5.00 |
| 2021-06-30 | $397k | 53k | 7.47 |
| 2021-03-31 | $302k | 51k | 5.88 |
| 2020-12-31 | $212k | 45k | 4.71 |
| 2020-09-30 | $120k | 35k | 3.43 |